Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia

Circulation

Volumn 110, Issue 3, 2004, Pages 247-252

  Nerheim, Pamela ^b   Birger Botkin, Sally ^b   Piracha, Lubna ^b   Olshansky, Brian ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b NONE

Author keywords

Arrhythmia; Death, sudden; Heart failure; Heart rate; Tachycardia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN;

ADULT; ARTICLE; BIGEMINAL HEART VENTRICLE EXTRASYSTOLE; CATHETER ABLATION; CLINICAL ARTICLE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART TRANSPLANTATION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC HEART VENTRICLE TACHYCARDIA; MALE; PAROXYSMAL TACHYCARDIA; PERMANENT JUNCTIONAL RECIPROCATING TACHYCARDIA; PRIORITY JOURNAL; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA INDUCED CARDIOMYOPATHY;

ADULT; AGED; CARDIAC OUTPUT, LOW; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; STROKE VOLUME; TACHYCARDIA; VENTRICULAR FUNCTION, LEFT;

EID: 3242726154     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000135472.28234.CC     Document Type: Article

References (47)

1. McLaran CJ, Gersh BJ, Sugrue DD, et al. Tachycardia induced myocardial dysfunction. A reversible phenomenon? Br Heart J. 1985;53: 323-327.
2. Anselme F, Boyle N, Josephson M. Incessant fascicular tachycardia: a cause of arrhythmia induced cardiomyopathy. Pacing Clin Electrophysiol. 1998;21:760-763.
3. Chiladakis JA, Vassilikos VP, Maounis TN, et al. Successful radiofrequency catheter ablation of automatic atrial tachycardia with regression of the cardiomyopathy picture. Pacing Clin Electrophysiol. 1997;20: 953-959.
4. Cruz FE, Cheriex EC, Smeets JL, et al. Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia. J Am Coll Cardiol. 1990;16:739-744.
5. Singh B, Kaul U, Talwar KK, et al. Reversibility of "tachycardia induced cardiomyopathy" following the cure of idiopathic left ventricular tachycardia using radiofrequency energy. Pacing Clin Electrophysiol. 1996;19:1391-1392.
6. Jaggarao NS, Nanda AS, Daubert JP. Ventricular tachycardia induced cardiomyopathy: improvement with radiofrequency ablation. Pacing Clin Electrophysiol. 1996;19:505-508.
7. Grimm W, Menz V, Hoffmann J, et al. Reversal of tachycardia induced cardiomyopathy following ablation of repetitive monomorphic right ventricular outflow tract tachycardia. Pacing Clin Electrophysiol. 2001;24: 166-171.
8. Packer DL, Bardy GH, Worley SJ, et al. Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. Am J Cardiol. 1986;57:563-570.
9. Rosenqvist M, Lee MA, Moulinier L, et al. Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junction. J Am Coll Cardiol. 1990;16:1467-1474.
10. Gillette PC, Smith RT, Garson A Jr, et al. Chronic supraventricular tachycardia: a curable cause of congestive cardiomyopathy. JAMA. 1985; 253:391-392.
11. Wu EB, Chia HM, Gill JS. Reversible cardiomyopathy after radiofrequency ablation of lateral free-wall pathway-mediated incessant supraventricular tachycardia. Pacing Clin Electrophysiol. 2000;23: 1308-1310.
12. Ott P, Kelly PA, Mann DE, et al. Tachycardia-induced cardiomyopathy in a cardiac transplant recipient: treatment with radiofrequency catheter ablation. J Cardiovasc Electrophysiol. 1995;6:391-395.
13. Harrigan JT, Kangos JJ, Sikka A, et al. Successful treatment of fetal congestive heart failure secondary to tachycardia. N Engl J Med. 1981; 304:1527-1529.
14. Manolis AG, Katsivas AG, Lazaris EE, et al. Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias. J Int Cardiac Electrophysiol. 1998;2: 71-76.
15. Grogan M, Smith HC, Gersh BJ, et al. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol. 1992;69:1570-1573.
16. Raymond RJ, Lee AJ, Messineo FC, et al. Cardiac performance early after cardioversion from atrial fibrillation. Am Heart J. 1998;136: 435-442.
17. Luchsinger JA, Steinberg JS. Resolution of cardiomyopathy after ablation of atrial flutter. J Am Coll Cardiol. 1998;32:205-210.
18. Simmers T, Sreeram N, Wittkampf F. Catheter ablation of sinoatrial re-entry tachycardia in a 2 month old infant. Heart. 2003;89:e1.
19. Rakovec P, Lajovic J, Dolenc M. Reversible congestive cardiomyopathy due to chronic ventricular tachycardia. Pacing Clin Electrophysiol. 1989; 12:542-545.
20. Noe P, Van Driel V, Wittkampf F, et al. Rapid recovery of cardiac function after catheter ablation of persistent junctional reciprocating tachycardia in children. Pacing Clin Electrophysiol. 2002;25:191-194.
21. Chugh SS, Shen WK, Luria DM, et al. First evidence of premature ventricular complex-induced cardiomyopathy: a potentially reversible cause of heart failure. J Cardiovasc Electrophysiol. 2000;11:328-329.
22. Soejima K, Delacretaz E, Stevenson WG, et al. DDD-pacing-induced cardiomyopathy following AV node ablation for persistent atrial tachycardia. J Int Cardiac Electrophysiol. 1999;3:321-323.
23. Van Gelder IC, Crijns HJ, Blanksma PK, et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol. 1993;72:560-566.
24. Spinale FG, Zellner JL, Tomita M, et al. Tachycardia-induced cardiomyopathy: effects on blood flow and capillary structure. Am J Physiol. 1991;261:H140-H148.
25. Spinale FG, Hendrick DA, Crawford FA, et al. Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine. Am J Physiol. 1990;259:H218-H229.
26. Spinale FG, Holzgrefe HH, Mukherjee R, et al. LV and myocyte structure and function after early recovery from tachycardia-induced cardiomyopathy. Am J Physiol. 1995;268:H836-H847.
27. Tibayan FA, Lai DT, Timek TA, et al. Alterations in left ventricular torsion in tachycardia-induced dilated cardiomyopathy. J Thorac Cardiovasc Surg. 2002;124:43-49.
28. Byrne MJ, Raman JS, Alferness CA, et al. An ovine model of tachycardia-induced degenerative dilated cardiomyopathy and heart failure with prolonged onset. J Cardiac Failure. 2002;8:108-115.
29. Eble DM, Spinale FG. Contractile and cytoskeletal content, structure, and mRNA levels with tachycardia-induced cardiomyopathy. Am J Physiol. 1995;268:H2426-H2439.
30. Kajstura J, Zhang X, Liu Y, et al. The cellular basis of pacing-induced dilated cardiomyopathy: myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation. 1995;92:2306-2317.
31. Timek TA, Dagum P, Lai DT, et al. Pathogenesis of mitral regurgitation in tachycardia-induced cardiomyopathy. Circulation. 2001;104(suppl I):I-47-I-53.
32. Spinale FG, Zellner JL, Johnson WS, et al. Cellular and extracellular remodeling with the development and recovery from tachycardia-induced cardiomyopathy: changes in fibrillar collagen, myocyte adhesion capacity and proteoglycans. J Mol Cell Cardiol. 1996;28:1591-1608.
33. Zellner JL, Spinale FG, Eble DM, et al. Alterations in myocyte shape and basement membrane attachment with tachycardia-induced heart failure. Circ Res. 1991;69:590-600.
34. Takahashi M, Tsutsui H, Kinugawa S, et al. Role of microtubules in the contractile dysfunction of myocytes from tachycardia-induced dilated cardiomyopathy. J Mol Cell Cardiol. 1998;30:1047-1057.
35. Coker ML, Thomas CV, Clair MJ, et al. Myocardial matrix metalloproteinase activity and abundance with congestive heart failure. Am J Physiol. 1998;274:H1516-H1523.
36. King MK, Coker ML, Goldberg A, et al. Selective matrix metalloproteinase inhibition with developing heart failure: effects on left ventricular function and structure. Circ Res. 003;92:177-185.
37. Burchell SA, Spinale FG, Crawford FA, et al. Effects of chronic tachycardia-induced cardiomyopathy on the beta-adrenergic receptor system. J Thorac Cardiovasc Surg. 1992;104:1006-1012.
38. 2+ release from cardiac sarcoplasmic reticulum in tachycardia-induced heart failure. Cardiovasc Res. 1999;44:146-155.
39. Ravens U, Davia K, Davies CH, et al. Tachycardia-induced failure alters contractile properties of canine ventricular myocytes. Cardiovasc Res. 1996;32:613-621.
40. (+)-ATPase activity and distribution with chronic supraventricular tachycardia. Cardiovasc Res. 1991;25:138-144.
41. (+)-ATPase in tachycardia induced cardiomyopathy. J Mol Cell Cardiol. 1992;24: 277-294.
42. St John Sutton M, Lee D, Rouleau JL, et al. Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. Circulation. 2003;107:2577-2582,
43. Spinale FG, Tomita M, Zellner JL, et al. Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia. Am J Physiol. 1991;261:H308-H318.
44. Spinale FG, Zellner JL, Tomita M, et al. Relation between ventricular and myocyte remodeling with the development and regression of supraventricular tachycardia-induced cardiomyopathy. Circ Res. 1991;69: 1058-1067.
45. Gallagher JJ. Tachycardia and cardiomyopathy: the chicken-egg dilemma revisited. J Am Coll Cardiol. 1985;6:1172-1173.
46. Afonso MR, Franca HH. Sudden death and tachycardiomyopathy in a young man with incessant tachycardia [in Portuguese]. Arq Bras Cardiol. 1992;58:303-306.
47. Pak PH, Nuss HB, Tunin RS, et al. Repolarization abnormalities, arrhythmia and sudden death in canine tachycardia-induced cardiomyopathy. J Am Coll Cardiol. 1997;30:576-584.